The Swiss-American multinational Philip Morris International Inc. PM, may join other cigarette producers that have already jumped into the cannabis industry.
What Happened
Marlboro is analyzing key components of the industry, such as the “toxicity of cannabis, efficacy and differences between pharmaceutical and consumer options,” reported Bloomberg News.
CEO Andre Calantzopoulos said the company is assessing the industry in detail because the market is still green and continues to face numerous regulation issues.
“We are doing all this work and will determine one day what avenues to pursue,” Calantzopoulos reportedly said.
“But our priority is what we’re doing with our smoke-free products, and that’s where I would stay on cannabis.”
Other Tobacco Companies In The Cannabis Industry
In 2018, Altria Group, Inc. MO invested CA$2.4 billion ($1.8 billion) in the cannabis company Cronos Group, Inc. CRON.
This March, British American Tobacco PLC BTI confirmed a CA$221-million investment in cannabis manufacturer OrganiGram Holdings, Inc. OGI
Although Philip Morris has already invested in cannabis-related Syqe Medical — an Israeli pharma-tech company — the investment was unrelated to cannabis products, but rather to secure “the exclusive global rights to technology for high-precision dosing for smoke-free tobacco products and nicotine applications,” according to Bloomberg.
If Philip Morris decides to jump into the cannabis industry, it will focus its participation on their “Beyond Nicotine” strategy.
PM Price Action: Philip Morris shares were down 0.38% at $94.15 at the close Wednesday.
Photo by Elsa Olofsson on Unsplash
© 2024 Benzinga.com. Benzinga does not provide investment advice. All rights reserved.
Comments
Trade confidently with insights and alerts from analyst ratings, free reports and breaking news that affects the stocks you care about.
Click on the image for more info.
Cannabis rescheduling seems to be right around the corner
Want to understand what this means for the future of the industry?
Hear directly for top executives, investors and policymakers at the Benzinga Cannabis Capital Conference, coming to Chicago this Oct. 8-9.
Get your tickets now before prices surge by following this link.